News

Syndesi Therapeutics announces appointment of Roy Twyman MD to its Board of Directors

Click to read the publication: 2018 10-SyndesiTherapeutics_PR_RTDirector_EN

A-MANSIA : 18 M€ and a high potential in the microbiote

After a first closing at 13 M€ in April 2018, …

Continue reading

Emolytics

Emolytics is a spin-off company of the Catholic University of …

Continue reading

NOVADIP announces …

NOVADIP announces … Click for more details    

AXINESIS announces …

AXINESIS announces … Click for more details      

VIROVET announces …

VIROVET announces … Click for more details

PROMETHERA announces …

PROMETHERA announces … Click for more details    

TESSARES announces …

TESSARES announces … Click for more details    

SMARTNODES announces …

SMARTNODES announces … Click for more details    

iTeos Therapeutics announces ….

iTeos Therapeutics announces …. Click for more details

OLYGOSE announces …

OLYGOSE announces … Click for more details    

GREEN2CHEM announces …

GREEN2CHEM announces … Click for more details

INTOPIX announces …

INTOPIX announces … Click for more details    

CISSOID announces …

CISSOID announces … Click for more details    

EMOLYTICS announces …

EMOLYTICS announces … Click for more details

XYLOWATT announces …

XYLOWATT announces … Click for more details    

(FR) On recherche un(e) Senior Business & Investment Manager

Sorry, this entry is only available in FR.